Sharon Huang is a venture investor at Tau Ventures who simultaneously continues her medical training at Mt. Sinai, giving her an unusual dual perspective as both a clinician-in-training and AI healthcare investor. She combines deep technical experience building automated sequencing pipelines at the Chan Zuckerberg Biohub with a systematic approach to healthcare investing that focuses on backend infrastructure and operational pain points rather than patient-facing applications. Sharon Huang is a venture investor at Tau Ventures who simultaneously continues her medical training at Mt. Sinai, giving her an unusual dual perspective as both a clinician-in-training and AI healthcare investor. She combines deep technical experience building automated sequencing pipelines at the Chan Zuckerberg Biohub with a systematic approach to healthcare investing that focuses on backend infrastructure and operational pain points rather than patient-facing applications.